US Oncology Image About Us | Careers | Contact Us | News Room

ADVANCE SEARCH
SEARCH RESULTS FOR "Cancer Centers of North Carolina"

23 Results -  < Previous  View Page 
 
 
1. Cancer Centers of North Carolina-Asheville, P.C. earns prestigious accreditation from the American College of Radiology
Asheville, NC and The Woodlands, TX (March 28, 2011) — Cancer Centers of North Carolina-Asheville, P.C. (CCNC-A), a private oncology practice serving Western North Carolina for more than 25 years, has been awarded a three-year term of accreditation in computed tomography (CT) as the result of a recent review by the American College of Radiology (ACR). This accomplishment demonstrates CCNC-A’s commitment to quality care. Cancer Centers of North Carolina-Asheville is united in healing with US Oncology, a division of McKesson Corporation and a leading integrated oncology company advancing cancer care by uniting one of the largest community-based cancer treatment and research networks in America. CT scanning — often referred to as CAT scanning — is a noninvasive medical test that helps physicians diagnose, tailor treatments, and monitor progress for a variety of medical conditions, including cancer.
Read More >
 
 
 
2. Cancer Centers of North Carolina Acquires Wake Radiology Oncology Services of Cary, N.C.
Cary, N.C. and The Woodlands, Texas (April 20, 2011) — Cancer Centers of North Carolina (CCNC), an affiliate of the United Network of US Oncology and the first practice to offer community-based outpatient cancer care in the Triangle with locations in Raleigh, North Raleigh, Cary, Dunn and Clayton, has purchased Wake Radiology Oncology Services (WROS) from Wake Radiology, the oldest and largest multi-site radiology group in central North Carolina.
Read More >
 
 
 
3. Cancer Centers of North Carolina - Asheville Implements iKnowMed™ Electronic Medical Record (EMR) from US Oncology
The Woodlands, Texas and Asheville, N.C. (Jan. 4, 2011) — Cancer Centers of North Carolina - Asheville (CCNCA), an affiliate of the United Network of US Oncology with two practices serving North Carolina, today announced that it has implemented iKnowMed™ EMR for its electronic medical record (EMR) system. iKnowMed EMR is a product of US Oncology, Inc., a leading integrated oncology company.
Read More >
 
 
 
4. Cancer Centers of North Carolina among first in the nation to treat advanced prostate cancer patients with PROVENGE
Raleigh, N.C. (May 19, 2011) — Cancer Centers of North Carolina (CCNC), an affiliate of US Oncology (a division of McKesson Corporation) and an 18-physician practice dedicated to offering state of the art compassionate cancer care, is among the first sites in the nation to treat advanced prostate cancer patients with PROVENGE® (sipuleucel-T), the first in a new therapeutic class known as autologous cellular immunotherapies. PROVENGE was approved by the U.S. Food and Drug Administration (FDA) for the treatment of men with asymptomatic or minimally symptomatic metastatic castrate resistant (hormone refractory) prostate cancer and is made by Dendreon Corporation.
Read More >
 
 
 
5. Cancer Centers of North Carolina Expands Gynecologic Oncology Program
Raleigh, N.C. (August 1, 2011) — Cancer Centers of North Carolina (CCNC), a 19- physician practice dedicated to community-based cancer care since 1979, is expanding its gynecologic oncology program through the addition of Jennifer M. Rubatt, MD.
Read More >
 
 
 
6. Raleigh Primary Care and Other Physicians Invited to Cancer Care Discussion
Raleigh, N.C. (Aug. 22, 2011) – Cancer Centers of North Carolina (CCNC), an affiliate of The US Oncology Network and a 18-physician practice dedicated to community-based cancer care since 1979, invites triangle area primary care providers including internists, family practitioners, hospitalists, and other healthcare providers to an interactive update and review of topics in Hematology and Oncology. The meeting will take place from 8:30 am to Noon, Saturday, Aug. 27, at Raleigh Crabtree Valley Marriott, 4500 Marriott Drive. Seating is limited. RSVP to 919-510-5666 or ncccncrsvp@usoncology.com.
Read More >
 
 
 
7. Cancer Centers of North Carolina Brings Innovative New Radiation Treatment to Wake County for Cervical and Rectal Cancer Patients
Raleigh, N.C. (January 14, 2013) — Cancer Centers of North Carolina (CCNC), a 19-physician practice dedicated to community-based cancer care since 1979, is now offering a new brachytherapy radiation treatment option for gynecologic and rectal cancer patients designed to increase patient comfort while providing more targeted therapy to the cancerous areas. With the support of The US Oncology Network, CCNC is the first oncology practice in Wake County to use this innovative device that has significant advantages for patients over prior brachytherapy treatment options.
Read More >
 
 
 
8. Cancer Centers of North Carolina receives recognition for Cancer Care from Largest Oncology Society in United States
Raleigh, N.C. (September 18, 2012) — Cancer Centers of North Carolina (CCNC), a 19- physician practice dedicated to community-based cancer care since 1979, has been recognized by the Quality Oncology Practice Initiative (QOPI®) Certification Program, an affiliate of the American Society of Clinical Oncology (ASCO). The QOPI® Certification Program provides a three-year certification for outpatient hematology-oncology practices that meet the highest standards for quality cancer care.
Read More >
 
 
 
9. Break-through Prostate Cancer Drug Now Available in North Carolina
Raleigh, NC (June 10, 2013)—Cancer Centers of North Carolina, a practice inThe US Oncology Network and a leading provider of comprehensive, state-of-the art cancer treatment in the Triangle area, is the first and only provider in the state of North Carolina to offer Xofigo, a ground-breaking treatment for advanced prostate cancer. According to the American Cancer Society’s Cancer Facts and Figures, 2013, approximately 238,500 men will be diagnosed with prostate cancer and about 29,700 will die from the disease in 2013.
Read More >
 
 
 
10. Cancer Centers of North Carolina-Asheville Wins Big for Inspirational Campaign
Cancer Centers of North Carolina-Asheville (CCNC-A), an affiliate of US Oncology, Inc. the nation’s leading integrated oncology company, took home numerous honors at the 27th Annual Healthcare Marketing Report Awards Competition. Out of 4,000 entries, CCNC-A’s “No Mountain Too High” campaign won 3rd overall (Bronze) in the total advertising campaign without television category. The motivational and artistic campaign also won Bronze in Radio and a Merit in the Outdoor/Transit category.
Read More >
 
 
 
11. The US Oncology Network affiliated physicians at forefront of cutting-edge prostate cancer treatment
The Woodlands, Texas (Sept. 30, 2011) — David, a 67-year-old father of three and soon to be first-time grandfather, felt too young to be diagnosed with prostate cancer. “I felt great,” he said. “I had no symptoms.” David, under the advisement of his oncologist, decided to be treated with PROVENGE® (sipuleucel-T), the first in a new therapeutic class known as autologous cellular immunotherapies.
Read More >
 
 
 
12. US Oncology Research affiliated physicians to present at 2011 ASCO Annual Meeting
The Woodlands, Texas (May 26, 2011) — McKesson Specialty Care Solutions | US Oncology, a division of McKesson Corporation, announced today that four physicians affiliated with US Oncology Research and the United Network of US Oncology will give oral presentations at the 47th Annual Meeting of the American Society of Clinical Oncology (ASCO) held June 3 - 7 at McCormick Place in Chicago.
Read More >
 
 
 
13. Virginia Cancer Specialists Adds Two New Medical Oncologists, Enhancing Access to Quality Care for Patients in Arlington and Loudoun
Fairfax, Va. (October 7, 2013) — Virginia Cancer Specialists (VCS), Virginia’s premier cancer care center providing 40 years of service to patients battling cancer and blood diseases and affiliated with The US Oncology Network, has announced the addition of two new medical oncologists to its practice. Keeran R. Sampat, M.D., joined the VCS Arlington office, while Amit Sarma, M.D., joined the VCS Loudoun facility. The new medical oncologists bring a unique combination of experience in clinical and academic medical oncology to the practice, in addition to training from some of the leading oncology centers in the country, adding new expertise and fresh perspectives to the VCS care team and expanding its services in Northern Virginia.
Read More >
 
 
 
14. US Oncology Affiliated Physicians To Present and Receive Honors at ASCO
US Oncology, Inc., the nation’s leading integrated oncology company, announced today that two physicians affiliated with US Oncology Research will be honored at the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO) held June 4 - 8 at McCormick Place in Chicago.
Read More >
 
 
 
15. US Oncology Affiliated Physicians Present Plenary, Oral and Poster Sessions at ASCO
Shaughnessy, M.D., presents today at a featured plenary session at ASCO on the study, “Efficacy of BSI-201, a poly (ADP-ribose) polymerase-1 (PARP1) inhibitor, in combination with gemcitabine/carboplatin (G/C) in patients with metastatic triple negative breast cancer (TNBC)
Read More >
 
 
 
16. Publication Support
Read More >
 
 
 
17. Two US Oncology Transplant Programs Earn FAHCT Accreditation
US Oncology (Nasdaq: USON) today announced that its Raleigh Hematology Oncology Blood and Marrow Transplant Program in Raleigh, N.C., and its Rocky Mountain Cancer Centers (RMCC) Autologous Stem Cell Transplant Program in Colorado Springs, Colo., have earned accreditation by the Foundation for the Accreditation of Hematopoietic Cell Therapy (FAHCT).
Read More >
 
 
 
18. Cancer Centers Of North Carolina
Read More >
 
 
 
19. Cancer Centers Of North Carolina Asheville
Read More >
 
 
 
20. Cancer Centers Of North Carolina Asheville
Read More >
 
 
 
21. Cancer Centers Of North Carolina
Read More >
 
 
 
22. US Oncology Reports Results for Second Quarter 2006
US Oncology Holdings, Inc. ("Holdings" or the "Company"), the parent company of US Oncology, Inc. ("US Oncology"), one of the nation's largest cancer care services companies, reported revenue of $689.4 million, EBITDA of $66.6 million and net income of $8.6 million for the quarter ended June 30, 2006. For the six months ended June 30, 2006 , the Company reported revenue of $1,391.2 million, EBITDA of $128.0 million and net income of $16.2 million.
Read More >
 
 
23. Chicago Tribune: Patient Assistance Support
Cancer patient Louisa Wilson, of the Chicago area, who is receiving treatment at Cancer Care & Hematology Specialists of Chicagoland, has benefited from US Oncology's Patient Assistance Support program. The program has helped Wilson gain financial assistance through a variety of community programs so that she may continue her cancer treatment.
Read More >
 
 
23 Results -  < Previous  View Page 
Global Navigation
About Us
Careers
Contact Us
News
Blog
 
Choose Your Path
Patients
Oncologists
Referring Physicians
Cancer Care Advocates
Legal and Policy
Terms of Use
For Employees
Sitemap
Technical Help
Follow Us:
Twitter YouTube
© 2014 McKesson Specialty Health. All rights reserved.